A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis

Kenneth B. Gordon*, Richard G. Langley, Alice B. Gottlieb, Kim A. Papp, Gerald G. Krueger, Bruce E. Strober, David A. Williams, Yihua Gu, Joaquin M. Valdes

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III, randomized, controlled trial of the fully human IL-12/23 mAb briakinumab in moderate-to-severe psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences